Real-world pharmacovigilance of adverse events associated with immune checkpoint and targeted inhibitors in digestive system tumors: A FAERS database study
{{output}}
ObjectiveDigestive system tumors (DST) remain a major contributor to the global cancer burden. This study aimed to characterize the adverse events (AEs) spectrum, identify potential safety signals, and explore subgroup-specific reporting patterns and time-to-o... ...
